001472084 000__ 05977cam\\22006257i\4500
001472084 001__ 1472084
001472084 003__ OCoLC
001472084 005__ 20230908003329.0
001472084 006__ m\\\\\o\\d\\\\\\\\
001472084 007__ cr\cn\nnnunnun
001472084 008__ 230728s2023\\\\sz\a\\\\o\\\\\001\0\eng\d
001472084 019__ $$a1391130473
001472084 020__ $$a9783031329975$$q(electronic bk.)
001472084 020__ $$a303132997X$$q(electronic bk.)
001472084 020__ $$z3031329961
001472084 020__ $$z9783031329968
001472084 0247_ $$a10.1007/978-3-031-32997-5$$2doi
001472084 035__ $$aSP(OCoLC)1391342194
001472084 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dYDX
001472084 049__ $$aISEA
001472084 050_4 $$aRC346
001472084 08204 $$a616.8$$223/eng/20230728
001472084 24500 $$aProgress in nanomedicine in neurologic diseases /$$cHari Shanker Sharma, Aruna Sharma, editors.
001472084 264_1 $$aCham, Switzerland :$$bSpringer,$$c2023.
001472084 300__ $$a1 online resource (312 pages) :$$billustrations (black and white, and color).
001472084 336__ $$atext$$btxt$$2rdacontent
001472084 337__ $$acomputer$$bc$$2rdamedia
001472084 338__ $$aonline resource$$bcr$$2rdacarrier
001472084 4901_ $$aAdvances in neurobiology ;$$vvolume 32
001472084 500__ $$aIncludes index.
001472084 5050_ $$aSection I: Neurodegenerative diseases -- Chapter 1: Nanowired delivery of cerebrolysin together with antibodies to amyloid beta peptide, phosphorylated tau and tumor necrosis factor alpha induces superior neuroprotection in Alzheimer's disease brain pathology exacerbated by sleep deprivation -- Chapter 2: Nanodelivery of histamine H3/H4 receptor modulators BF2649 and clobenpropit with antibodies to amyloid beta peptide in combination with alpha synuclein reduces brain pathology in Parkinson's disease -- Chapter 3: Co-administration of nanowired DL-3-n-butylphthalide (DL-NBP) together with mesenchymal stem cells, monoclonal antibodies to alpha synuclein and TDP-43 (TAR DNA-binding protein 43) enhance superior neuroprotection in Parkinson's disease following concussive head injury -- Chapter 4: Neuroprotective effects of nanowired delivery of cerebrolysin with mesenchymal stem cells and monoclonal antibodies to neuronal nitric oxide synthase in brain pathology following Alzheimers disease exacerbated by concussive head injury -- Section II: Central Nervous system Trauma -- Chapter 5: Co-administration of nanowired monoclonal antibodies to inducible nitric oxide synthase and tumor necrosis factor-alpha together with antioxidant H-290/51 reduces SiO2-nanoparticles induced exacerbation of pathophysiology of spinal cord trauma -- Chapter 6: Nanowired delivery of cerebrolysin with mesenchymal stem cells attenuates heat stress induced exacerbation of neuropathology following brain blast injury -- Chapter 7: Co-administration of nanowired oxiracetam and neprilysin with monoclonal antibodies to amyloid beta peptide and p-tau thwarted exacerbation of brain pathology in concussive head injury at hot environment -- Section III. Stress and Drugs of abuse -- Chapter 8: Nanowired delivery of mesenchymal stem cells with antioxidant compound H-290/51 reduces exacerbation of methamphetamine neurotoxicity in hot environment -- Chapter 9: TiO2-nanowired delivery of Chinese extract of Gingko biloba EGb-761 and bilobalide BN-52021 enhanced neuroprotective effects of cerebrolysin following spinal cord injury at cold environment -- Chapter 10: Nanowired delivery of curcumin attenuates methamphetamine neurotoxicity and elevates levels of dopamine and brain derived neurotrophic factor.
001472084 506__ $$aAccess limited to authorized users.
001472084 520__ $$aThis book covers the use of nanomedicine in the delivery of neuroprotective agents, including pharmacological drugs, stem cells, neurotrophic factors, monoclonal antibodies and enzymes to induce greater beneficial effects in neurologic diseases. Thus, the main purpose of the book is to explore the delivery of drugs either alone or in combination with stem cells to enhance neuroprotection in neurological diseases. Brain pathology associated with acute trauma such as head injury and brain blast injury can also be managed using novel treatment strategies. In addition, emphasis is made that standard patterns of brain pathology may be complicated with multiple comorbidity factors where one agent alone is not sufficient to induce brain protection. Enzymes and antibodies may help in combination and enhance the efficacy when administered through nanotechnology. Progress in Nanomedicine in Neurologic Diseases will encourage further research in the field of neuroprotection, brain injury, neurodegenerative diseases, neuropharmacology, neuropathology, and neurology. Students and researchers along with policy makers, teachers and health care professionals may also benefit from the findings of the book for enhanced patients care.
001472084 588__ $$aDescription based on print version record.
001472084 650_0 $$aNervous system$$xDiseases$$xTechnological innovations.
001472084 650_0 $$aNanomedicine.
001472084 655_0 $$aElectronic books.
001472084 7001_ $$aSharma, Hari Shanker,$$eeditor.
001472084 7001_ $$aSharma, Aruna,$$eeditor.
001472084 77608 $$iPrint version:$$tPROGRESS IN NANOMEDICINE IN NEUROLOGIC DISEASES.$$d[Place of publication not identified] : SPRINGER INTERNATIONAL PU, 2023$$z3031329961$$w(OCoLC)1375536504
001472084 830_0 $$aAdvances in neurobiology ;$$v32.
001472084 852__ $$bebk
001472084 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-031-32997-5$$zOnline Access$$91397441.1
001472084 909CO $$ooai:library.usi.edu:1472084$$pGLOBAL_SET
001472084 980__ $$aBIB
001472084 980__ $$aEBOOK
001472084 982__ $$aEbook
001472084 983__ $$aOnline
001472084 994__ $$a92$$bISE